Gabapentin for inflammation
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Inflammation: A Comprehensive Review
Introduction to Gabapentin and Inflammation
Gabapentin, originally developed as an anticonvulsant, has shown promise in treating various types of pain, including neuropathic and inflammatory pain. Recent studies have explored its potential anti-inflammatory effects, suggesting that gabapentin may modulate inflammatory responses through various mechanisms.
Gabapentin's Role in Acute Inflammatory Pain
Thermal Injury and Mechanical Allodynia
A study investigating gabapentin's effects on acute inflammatory pain induced by thermal injury found that while gabapentin did not significantly alter heat pain thresholds or pain during the burn, it did reduce primary mechanical allodynia in the burn area1. This suggests that gabapentin may have specific applications in managing mechanical pain associated with acute inflammation.
Gabapentin in Gastrointestinal Inflammation
Colitis Models
Gabapentin has demonstrated significant anti-inflammatory effects in experimental models of colitis. In a study using trinitrobenzenesulfonic acid to induce colitis in rats, gabapentin reduced macroscopic and microscopic lesions, oxidative stress markers, and pro-inflammatory cytokines such as IL-1β and TNF-α. These effects were mediated through the activation of the PPAR-gamma receptor, which inhibits NFκB activation, a key regulator of inflammation2. Another study confirmed these findings, showing that gabapentin reduced colonic lesions and inflammatory markers in acetic acid-induced colitis in rats4.
Gabapentin in Ocular Inflammation
Uveitis Model
Gabapentin has also been effective in reducing ocular inflammation. In a rabbit model of endotoxin-induced uveitis, gabapentin significantly decreased the production of inflammatory mediators such as TNF-α, IL-1β, COX-2, and PGE2. Topical application of gabapentin reduced clinical signs of inflammation, suggesting its potential use in treating inflammatory eye conditions3.
Gabapentin in Respiratory Inflammation
Asthma Model
In a mouse model of ovalbumin-induced allergic asthma, gabapentin significantly reduced lung inflammation, oxidative stress, and pro-inflammatory cytokines such as IL-4, IL-13, and TNF-α. These findings indicate that gabapentin may have therapeutic potential in managing chronic inflammatory lung diseases like asthma5.
Gabapentin in Joint Inflammation
Arthritis Model
Gabapentin has shown efficacy in reducing nociceptive behaviors in a rat model of acute arthritis induced by kaolin and carrageenan. It prevented the development of heat hyperalgesia and other pain-related behaviors when administered both before and after the induction of inflammation. However, it did not affect joint swelling, indicating that its primary action may be on pain modulation rather than reducing physical inflammation6.
Chronic Administration and Systemic Inflammation
Formalin-Induced Inflammation
Chronic administration of gabapentin has been shown to reduce paw edema and increase edema inhibition in a formalin-induced inflammation model in rats. These effects were more pronounced than those observed with the reference anti-inflammatory drug, diclofenac, suggesting that gabapentin may have potent systemic anti-inflammatory properties8.
Gabapentin Derivatives and Combined Therapies
Gabapentsal and Combined Ibuprofen-Gabapentin
A derivative of gabapentin, gabapentsal, has been evaluated for its anti-inflammatory and analgesic properties. It was effective in reducing inflammatory edema and pyrexia in various models, implicating both opioidergic and GABAergic mechanisms in its action9. Additionally, a newly synthesized compound combining ibuprofen and gabapentin showed significant analgesic and anti-inflammatory activities, potentially offering a more effective therapeutic option for managing pain and inflammation7.
Mechanistic Insights
Cytokine Modulation
Gabapentin's anti-inflammatory effects are partly mediated through the modulation of cytokine expression. In a neuropathic pain model, gabapentin increased the expression of the anti-inflammatory cytokine IL-10 while reducing pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. The anti-allodynic effects of gabapentin were partially blocked by an anti-IL-10 antibody, highlighting the importance of IL-10 in its mechanism of action10.
Conclusion
Gabapentin exhibits significant anti-inflammatory properties across various models of inflammation, including gastrointestinal, ocular, respiratory, and joint inflammation. Its effects are mediated through multiple pathways, including cytokine modulation and receptor activation. These findings suggest that gabapentin could be a valuable therapeutic agent for managing inflammatory conditions, warranting further clinical investigation.
Sources and full results
Most relevant research papers on this topic
Effects of Gabapentin in Acute Inflammatory Pain in Humans
Gabapentin may reduce primary mechanical allodynia in acute inflammation following a thermal injury, suggesting potential for postoperative pain treatment.
RCT
Highly CitedGabapentin attenuates intestinal inflammation: Role of PPAR-gamma receptor.
Gabapentin reduces intestinal inflammation by regulating mast cell signaling and activating the PPAR-gamma receptor, which in turn inhibits NFB activation and inflammatory genes.
Non-RCT
Animal Study
Rigorous JournalGabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies
Ophthalmic formulations based on gabapentin may be useful in treating inflammatory conditions associated with ocular pain like uveitis.
Non-RCTAnimal StudyAn investigation of the anti-inflammatory effects of gabapentin on acetic acid-induced colitis in rats
Gabapentin shows promising anti-inflammatory effects in acetic acid-induced colitis in rats, suggesting it could be a potential therapeutic agent for inflammatory bowel disease treatment.
RCTAnimal StudyRigorous JournalModulatory role of gabapentin against ovalbumin-induced asthma, bronchial and airway inflammation in mice.
Gabapentin shows anti-inflammatory and anti-allergic properties in mice with ovalbumin-induced allergic asthma, mainly due to its modulatory effect on IL-4, IL-13, and TNF activities.
Non-RCTAnimal StudyA newly synthetic compound of Ibuprofen and Gabapentin as a novel analgesic and anti-inflammatory therapeutic agent: A pharmacological study in rats’ experimental models
The newly synthesized compound (ibuprofen-gabapentin) significantly reduces pain and has significant anti-inflammatory properties compared to conventional compounds in rats.
RCTAnimal StudyThe Effects of Chronic Gabapentin Administration on the Inflammatory Response in Rats
Chronic gabapentin administration has a more effective antiinflammatory effect than diclofenac, suggesting potential benefits for neuropathic and inflammatory pain management.
RCTPharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia
Gabapentsal effectively reduces pain and inflammation in animal models, with potential applications in treating chronic pain and inflammatory conditions.
Non-RCTAnimal StudyIntrathecal Gabapentin Increases Interleukin-10 Expression and Inhibits Pro-Inflammatory Cytokine in a Rat Model of Neuropathic Pain
Intrathecal gabapentin reduces neuropathic pain by increasing interleukin-10 expression and inhibiting pro-inflammatory cytokine expression in the spinal cord.
Non-RCTAnimal StudyRigorous Journal